GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » Beneish M-Score

Par Drugs and Chemicals (NSE:PAR) Beneish M-Score : -3.08 (As of Apr. 02, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.08 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Par Drugs and Chemicals's Beneish M-Score or its related term are showing as below:

NSE:PAR' s Beneish M-Score Range Over the Past 10 Years
Min: -3.08   Med: -2.56   Max: -1.9
Current: -3.08

During the past 8 years, the highest Beneish M-Score of Par Drugs and Chemicals was -1.90. The lowest was -3.08. And the median was -2.56.


Par Drugs and Chemicals Beneish M-Score Historical Data

The historical data trend for Par Drugs and Chemicals's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals Beneish M-Score Chart

Par Drugs and Chemicals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beneish M-Score
Get a 7-Day Free Trial -2.29 -2.74 -1.90 -2.55 -3.08

Par Drugs and Chemicals Quarterly Data
Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -3.08 - - -

Competitive Comparison of Par Drugs and Chemicals's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Par Drugs and Chemicals's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Par Drugs and Chemicals's Beneish M-Score falls into.


;
;

Par Drugs and Chemicals Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Par Drugs and Chemicals for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.81+0.528 * 0.7921+0.404 * 0.775+0.892 * 1.0001+0.115 * 1.0048
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1703+4.679 * -0.056568-0.327 * 0.7777
=-3.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₹138 Mil.
Revenue was ₹951 Mil.
Gross Profit was ₹362 Mil.
Total Current Assets was ₹596 Mil.
Total Assets was ₹1,016 Mil.
Property, Plant and Equipment(Net PPE) was ₹413 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹34 Mil.
Selling, General, & Admin. Expense(SGA) was ₹70 Mil.
Total Current Liabilities was ₹124 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.
Net Income was ₹145 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹202 Mil.
Total Receivables was ₹170 Mil.
Revenue was ₹951 Mil.
Gross Profit was ₹287 Mil.
Total Current Assets was ₹494 Mil.
Total Assets was ₹889 Mil.
Property, Plant and Equipment(Net PPE) was ₹387 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹32 Mil.
Selling, General, & Admin. Expense(SGA) was ₹60 Mil.
Total Current Liabilities was ₹140 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(138.09 / 951.065) / (170.454 / 950.951)
=0.145195 / 0.179246
=0.81

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(286.902 / 950.951) / (362.239 / 951.065)
=0.3017 / 0.380877
=0.7921

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (596.236 + 413.35) / 1016.111) / (1 - (494.37 + 386.945) / 888.679)
=0.006422 / 0.008286
=0.775

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=951.065 / 950.951
=1.0001

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(32.332 / (32.332 + 386.945)) / (34.361 / (34.361 + 413.35))
=0.077114 / 0.076748
=1.0048

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(70.223 / 951.065) / (59.998 / 950.951)
=0.073836 / 0.063093
=1.1703

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 124.391) / 1016.111) / ((0 + 139.894) / 888.679)
=0.122419 / 0.157418
=0.7777

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(145.01 - 0 - 202.489) / 1016.111
=-0.056568

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Par Drugs and Chemicals has a M-score of -3.08 suggests that the company is unlikely to be a manipulator.


Par Drugs and Chemicals Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Par Drugs and Chemicals Business Description

Traded in Other Exchanges
N/A
Address
Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007
Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage. The company is dealing in only one segment i.e. manufacturing industry, API.